Apply Lessons Learned from EU MDR Compliance Programs to Future Remediation Challenges
The pace of major medtech regulatory challenges, such as complying with EU MDR, eliminating PFAS, and reducing EtO emissions, is accelerating. Compliance is no longer just an initial development cost. It’s an ongoing strategic investment in the future. To remain competitive, medical device companies need to get better at remediation.
Integrated Project Management Company has led multiple medical device companies through EU MDR remediation and other compliance programs. To sustain progress, you must:
- Understand the scale of the work
- Align compliance with strategic priorities
- Build a scalable governance and accountability framework
- Focus first on what matters most
- Build and maintain executive buy-in and advocacy
Download the article for the lessons we learned that will help executives and regulatory leaders complete MDR compliance while preparing their organizations for future global regulation changes.
Carl Manthe is a Director in IPM’s Los Angeles office. He has been managing complex projects for more than 30 years and has extensive experience leading teams in product development, business process optimization, change management, capital expansion, quality, portfolio management, and business integration projects.
Related Links
Services: Quality and Compliance
Industries: Medical Devices, Diagnostics, and Technology